Chemoradiotherapy Increases Intratumor Heterogeneity of HPSE Expression in the Relapsed Glioblastoma Tumors
Adjuvant chemoradiotherapy is a standard treatment option for glioblastoma multiforme (GBM). Despite intensive care, recurrent tumors developed during the first year are fatal for the patients. Possibly contributing to this effect, among other causes, is that therapy induces changes of polysaccharid...
Main Authors: | Anastasia V. Suhovskih, Galina M. Kazanskaya, Alexander M. Volkov, Alexandra Y. Tsidulko, Svetlana V. Aidagulova, Elvira V. Grigorieva |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-02-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/21/4/1301 |
Similar Items
-
Heparan Sulfate Biosynthetic System Is Inhibited in Human Glioma Due to EXT1/2 and HS6ST1/2 Down-Regulation
by: Victor S. Ushakov, et al.
Published: (2017-11-01) -
Chemotherapy-Induced Degradation of Glycosylated Components of the Brain Extracellular Matrix Promotes Glioblastoma Relapse Development in an Animal Model
by: Alexandra Y. Tsidulko, et al.
Published: (2021-07-01) -
Elucidating the Consequences of Heparan Sulfate Binding by Heparanase 2
by: Miriam Gross-Cohen, et al.
Published: (2021-01-01) -
New classes of potent heparanase inhibitors from ligand-based virtual screening
by: Daniele Pala, et al.
Published: (2020-01-01) -
Caractérisation des glycosaminoglycannes au cours de la croissance tumorale. Développement d’un nouvel outil pour leur étude : l’impression moléculaire
by: Mothere, Mouna
Published: (2013)